Total Raised

$165.58M

Investors Count

17

Deal Terms

2

Funding, Valuation & Revenue

11 Fundings

Ultraleap has raised $165.58M over 11 rounds.

Ultraleap's latest funding round was a Acquired for on November 11, 2025.

Ultraleap's 2022 revenue was $4.36M. Ultraleap's most recent revenue is from 2022.

Sign up for a free demo to see revenue data from 2024, 2022 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/11/2025

Acquired

$XXM

$X.XXB

((X.XXx))

FY XXXX

3

11/18/2021

Series D

$80.85M

$XXM

$4.36M

FY 2022

3

4/19/2021

Incubator/Accelerator

$XXM

$X.XXB

((X.XXx))

FY XXXX

1

8/20/2019

Secondary Market

$XXM

0

FY undefined

10

8/20/2019

Shareholder Liquidity

$XXM

0

FY undefined

10

Date

11/11/2025

11/18/2021

4/19/2021

8/20/2019

8/20/2019

Round

Acquired

Series D

Incubator/Accelerator

Secondary Market

Shareholder Liquidity

Amount

$80.85M

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

$4.36M

FY 2022

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

0

FY undefined

Sources

3

3

1

10

10

Start free trial
New call-to-action

Ultraleap Deal Terms

2 Deal Terms

Ultraleap's deal structure is available for 2 funding rounds, including their Series B from May 03, 2017.

Round

Series B

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Ultraleap Investors

17 Investors

Ultraleap has 17 investors. ROLI invested in Ultraleap's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/11/2025

11/11/2025

1
Acquired

Corporation

United Kingdom

11/2/2015

11/18/2021

4
Series A, Series B (2017), Series C (2018), Series D (2021)

Venture Capital

United Kingdom

12/3/2018

11/18/2021

3
Series C, Secondary Market (2019), Series D (2021)

Private Equity

United Kingdom

00/00/0000

00/00/0000

British Patient Capital

Subscribe to see more

Venture Capital

United Kingdom

00/00/0000

00/00/0000

Tencent

Subscribe to see more

Corporation

China

First funding

11/11/2025

11/2/2015

12/3/2018

00/00/0000

00/00/0000

Last Funding

11/11/2025

11/18/2021

11/18/2021

00/00/0000

00/00/0000

Investor

British Patient Capital

Tencent

Rounds

1
Acquired
4
Series A, Series B (2017), Series C (2018), Series D (2021)
3
Series C, Secondary Market (2019), Series D (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Private Equity

Venture Capital

Corporation

Location

United Kingdom

United Kingdom

United Kingdom

United Kingdom

China

Ultraleap Acquisitions

1 Acquisition

Ultraleap acquired 1 company. Their latest acquisition was Leap Motion on May 30, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/30/2019

Series C

$XXM

$94.05M

Acquired

2

Date

5/30/2019

Investment Stage

Series C

Companies

Valuation

$XXM

Total Funding

$94.05M

Note

Acquired

Sources

2

New call-to-action

Compare Ultraleap to Competitors

Q
Quantanx

Quantanx specializes in immersive technology within the virtual reality and haptic feedback domain. The company's main offerings include haptic wearable gloves that enable users to interact with virtual objects, providing tactile and temperature feedback for a realistic experience. Quantanx's products are primarily utilized in the ed-tech, gaming, and space research sectors. It was founded in 2020 and is based in Bangalore, India.

HaptX Logo
HaptX

HaptX focuses on touch simulation technology in the virtual reality and robotics fields. The company provides HaptX Gloves G1, which enable touch feedback in virtual environments, and HaptX SDK, a software development kit for developing haptic experiences. HaptX serves sectors that involve training and manual dexterity, including healthcare and manufacturing. HaptX was formerly known as AxonVR. It was founded in 2012 and is based in Redmond, Washington.

VRgluv Logo
VRgluv

VRgluv has developed a haptic glove for VR that features full finger tracking, force feedback, pressure sensitivity, and fits entirely on the hand.

CyberGlove Systems Logo
CyberGlove Systems

CyberGlove Systems focuses on data glove technology in virtual reality and motion capture. The company offers products that capture and simulate hand movements, allowing interaction with 3D environments and virtual objects. These products are used in sectors such as motion capture, industrial engineering, and academic research. It is based in San Jose, California.

M
Manus

MANUS focuses on hand tracking and motion capture technology within the entertainment, VR/XR, robotics, and life sciences sectors. The company provides products including motion capture gloves and body tracking systems for performance capture, virtual training, teleoperation, and research applications. MANUS products are compatible with industry-standard software, allowing for interactions with haptic feedback for various professional and research purposes. It was founded in 2014 and is based in Eindhoven, Netherlands.

S
Straythink

Straythink makes haptic feedback gloves to make virtual reality more immersive by using vibrations to simulate a hand touching an object.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.